The Challenge
Complex resistance mutations that reduce immunotherapy effectiveness, limiting treatment options.
Our Impact
We explained how her mutations influence treatment resistance and identified strategies including dual checkpoint inhibitors and mutation-specific trials. We also provided evidence for dose adjustments to discuss with her doctor to manage side effects while maintaining efficacy.
The Outcome
She achieved sustained disease control with improved quality of life. By integrating precision oncology expertise with personal, ongoing support, we helped Roberta and her family navigate a treatment landscape shaped by rare and complex genomics.
